Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
29.05. | BioAffinity Technologies Secures Patent for Novel Cancer Therapy Targeting CD320 and LRP2 Receptors | 3 | Insider Monkey | ||
27.05. | bioAffinity Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
20.05. | bioAffinity Technologies names new chief medical officer | 2 | Investing.com | ||
20.05. | bioAffinity Technologies appoints Gordon Downie as chief medical officer | 2 | Seeking Alpha | ||
BIOAFFINITY TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
19.05. | bioAffinity Technologies, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
15.05. | bioAffinity Technologies, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
15.05. | bioAffinity Technologies GAAP EPS of -$0.16, revenue of $1.9M | 1 | Seeking Alpha | ||
08.05. | bioAffinity Technologies, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
07.05. | bioAffinity Technologies completes $3.25 million offering | 1 | Investing.com | ||
07.05. | bioAffinity Technologies schließt Kapitalerhöhung von 3,25 Millionen US-Dollar ab | 5 | Investing.com Deutsch | ||
06.05. | bioAffinity kündigt Wertpapierangebot von 3,25 Millionen US-Dollar an | 9 | Investing.com Deutsch | ||
06.05. | bioAffinity announces $3.25 million securities offering | - | Investing.com | ||
05.05. | bioAffinity Technologies, Inc. - S-1/A, General form for registration of securities | 2 | SEC Filings | ||
02.05. | bioAffinity Technologies, Inc. - S-1, General form for registration of securities | 3 | SEC Filings | ||
29.04. | bioAffinity Technologies, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
17.04. | bioAffinity Technologies optimiert Lungenkrebs-Erkennungstest | 2 | Investing.com Deutsch | ||
17.04. | bioAffinity Technologies streamlines lung cancer detection test | 1 | Investing.com | ||
17.04. | RedChip Companies, Inc.: ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 399 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 17, 2025 / RedChip Companies will air interviews with ASP Isotopes Inc. (NASDAQ:ASPI) and bioAffinity Technologies, Inc. (NASDAQ:BIAF) on the RedChip Small Stocks... ► Artikel lesen | |
14.04. | bioAffinity Technologies, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
11.04. | bioAffinity Technologies, Inc. - S-1, General form for registration of securities | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PALATIN TECHNOLOGIES | 0,088 | 0,00 % | Palatin Technologies Q1 Net Loss Narrows On Lower Expenses | WASHINGTON (dpa-AFX) - Palatin Technologies, Inc. (PTNT.PK), a biopharmaceutical company, on Wednesday reported narrower net loss in its first quarter with sharply lower operating expenses.Palatin... ► Artikel lesen | |
BIOXXMED | 0,410 | 0,00 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 31.03.2025 | The following instruments on Xetra do have their last trading day on 31.03.2025.Die folgenden Instrumente auf Xetra haben ihren letzten Handelstag am 31.03.2025.ISIN NameDE000A4BGGE4 bioXXmed AG ► Artikel lesen | |
VIVOSIM LABS | 1,570 | -100,00 % | VivoSim Labs, INC. - 10-K, Annual Report | ||
OCUGEN | 0,925 | +10,94 % | Ocugen, Inc. Announces Signing of Binding Term Sheet for the License of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea | Upfront fees and near-term development milestone payments totaling up to $11 millionSales milestones of $150 million or more in first 10 years of commercializationRoyalties equaling 25% of net salesOcugen... ► Artikel lesen | |
SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem gibt Finanzierung mittels Wandelschuldverschreibung bekannt | Vancouver, British Columbia, 22. April 2025 / IRW-Press / Sirona Biochem Corp. (TSX-V: SBM) (FWB: ZSB) (OTC: SRBCF) ("Sirona" oder das "Unternehmen") gibt eine nicht vermittelte Privatplatzierung... ► Artikel lesen | |
BIO-GATE | 1,050 | 0,00 % | Bio-Gate beschließt Ausgabe einer Wandelschuldverschreibung unter Ausschluss des Bezugsrechts | Nürnberg (www.anleihencheck.de) - Bio-Gate beschließt Ausgabe einer Wandelschuldverschreibung unter Ausschluss des Bezugsrechts - AnleihenewsVorstand und Aufsichtsrat der Bio-Gate AG (ISIN DE000BGAG981/... ► Artikel lesen | |
DEFENCE THERAPEUTICS | 0,548 | +10,48 % | Defence Therapeutics Inc.: Defence Therapeutics Opens U.S. Laboratory in Boston-Cambridge Biotech Hub | Montreal, Quebec--(Newsfile Corp. - June 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a leading biotechnology company specializing in advanced... ► Artikel lesen | |
VAXART | 0,364 | +5,63 % | Vaxart, Inc.: Vaxart Announces Adjournment of Annual Meeting of Stockholders | ||
BURCON NUTRASCIENCE | 0,072 | -1,37 % | Burcon NutraScience Corporation: Burcon to Participate in 2025 Canadian Climate Investor Conference | Vancouver, British Columbia--(Newsfile Corp. - May 28, 2025) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"), a global technology leader in the development of... ► Artikel lesen | |
CELLECTAR BIOSCIENCES | 0,330 | -6,25 % | Cellectar +147%: Ich nehme die Gewinne mit! | Meine Spekulation geht auf: Cellectar Biosciences (WKN: A3DQSD) knallt heute in der Spitze um bis zu +147% durch die Decke, nachdem ich im März ein großes Comeback der Aktie in Aussicht gestellt hatte.... ► Artikel lesen | |
IDORSIA | 2,155 | +1,41 % | Idorsia Pharmaceuticals Ltd: Idorsia publishes invitations to bondholder meetings | Ad hoc announcement pursuant to Art. 53 LR
Bondholder meetings will take place on Wednesday, June 25, 2025, to vote on proposals to amend the terms of the two outstanding convertible bonds CB 2025... ► Artikel lesen | |
AFFIMED | 0,972 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.05.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.05.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.05.2025ISIN NameBMG3728V1090 GAN... ► Artikel lesen | |
GINKGO BIOWORKS | 6,550 | +3,15 % | Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer | BOSTON, May 21, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and... ► Artikel lesen | |
AIM IMMUNOTECH | 0,073 | -100,00 % | AIM ImmunoTech Inc.: AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market | OCALA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. ("AIM" or the "Company") (OTC Pink: AIMI) - an immuno-pharma company focused on the research and development of therapeutics to... ► Artikel lesen | |
IMMUNIC | 0,681 | +1,79 % | Immunic sammelt 65 Millionen Dollar ein - Aktie reagiert | Immunic meldet für die erste Tranche einer Kapitalmaßnahme einen Bruttoerlös von rund 65 Millionen Dollar. Das Biotech-Unternehmen platzierte im Rahmen eines öffentlichen Angebots vorfinanzierte Aktien-Warrants... ► Artikel lesen |